Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05744583Not ApplicableRecruiting

Finnish Prehospital Whole Blood Study

Role: lead

NCT04730401Phase 2Unknown

Convalescent Plasma in the Treatment of Covid-19

Role: collaborator

NCT01638416Phase 3Completed

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Role: collaborator

NCT03996304Unknown

Health and Early Life Microbiota

Role: collaborator

NCT02068755Completed

Blood Products in Cardiac Surgery

Role: collaborator

NCT01738256Not ApplicableCompleted

Study of Effectiveness of Different Lifestyle Interventions for Health and Wellbeing

Role: collaborator

NCT01119404Unknown

Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis

Role: collaborator

NCT01119690Not ApplicableCompleted

Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function

Role: collaborator

All 8 trials loaded